# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.
Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, dec...
Tuesday saw 9 companies set new 52-week lows.
U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 300 points on Tuesday.
Viveve Medical, Inc. (NASDAQ: VIVE) today announced topline result from the U.S. Pivotal PURSUIT clinical trial. PURSUIT was a...